Member Info for Donato84

If its in the importance of the public health as we know the government is very much trying to push the genomic angle( more data to know everything about you) they have a blank cheque for the right technology. Your comments only focus on the short term financing issues and lack of revenue which is already reflective of where the SP is, your comments do not however reflect the opportunity of 1) takeover 2) global utilisation 3) JV or Partnership with big pharma. All could come at any time and typically when the SP of a share is low. How comes you never mention these important points if you are considering "analysing" a share ..

The peanuts figure could be a lot more than the current price.

Note the language of this user, look at their historic posts, keeps repeating the word "worthless"- shows a strong agenda here, either could be a MM or short. Either way look forward to seeing what they have to say if this recovers sharply..

Another brokerage taken out, could be positive read across here. GL

I disagree the fact someone is willing to put up 1m is a supreme sign of confidence, dont forget the IP and tech is not exactly liquid. The RNS states "When drawn the Loan will be secured against a fixed and floating charge over all of the Company's assets including its intellectual property and patents, until repaid in full." I dont know what other debt GDR has but this financing infers the technology and assets etc is worth far north of £1m, the words until repaid in full is key here, there should be far in excess of that to be returned to shareholders after repayment if this came to it, only my opinion but this looks very good from here either way. This is not factoring in the next update relating to any potential contract wins that could be another win.

Does anyone know definitely that the tax losses cannot be used, correct if mistaken but if the post RTO was a continuation of existing business or similar the losses can be taken up? This would then make sense to a mid size challenger bank etc, would be a very attractive shell as such..

These are all good questions, I personally believe Stamp has been terrible for the company, he needs to be replaced, also I am trying to find out more about this CMS Medical Venture Investment, what their connection is. The company has attended multiple conferences over the last 6 months, surprised no deals have come out of them, notice though J&J have an interest in the new company, they are some how connected between the two, once again the private investor getting low balled by big pharma, hopefully they dont get the votes to push this dillution through, they should concentrate returning value through their existing pipeline..

People here are so stupid to whats going on here, even if the company does go public the directors to take the position fully private would still have to offer a substantial premium to entice any investors to part with their stock I believe, these private deals are becoming more common, the likes of asset match etc, have the ability for large holders of the stock to try and low ball the remaining 25% but if they are not in any particular rush eventually they will pay a price worth taking otherwise they wont own the company I believe, but do your own research of course, I recently sold my fastjet shares on asset match which I thought were worthless for £30/share, just because something comes off exchange doesnt mean its dead and has no value..people are making people believe this is the case, if you can afford to hold then it could be profitable in my opinion..

With reference to the TR1 announced on the 04/04 Steve Bassi has a holding it seems of more than 30%, does this not mean if im not mistaken there is a mandatory bid situation? How come nobody is talking about this?

yes I think it was April RNS, regarding Polar, wanted to know the companies cash position as of today. I think this makes a tempting entry below 175 level(DYOR) but then again could languish for days/months and drift down, as with mainly most Biotechs-they tend to keep the small PIs waiting for their news..

This share is one I have looked at from time to time, they have such an unusual trading pattern, with todays placing one again shows using claims of "breakthrough" sciences to fund what so far has been a bit of a dud company. Nothing but down since IPO, cant believe this once was £2 a share, what happened to the DARA acquisition?..down the pan? seems like all these guys do is burn through cash, millions spent up until now, with little or no revenue. PIs get spiked on this frequently it seems since there is such a low float, float since this raise should be higher now so technically improving liquidity. Everyone was hoping for a massive short squeeze on this think they will be disappointed. I think the news regarding secura bio was a red herring, also the other bits regarding their cancer treatments, the treatment is for a niche and small market. The real value here is the next gen vax development, if they bolted their tech onto this could have big rewards if proven. Then again, this could be just trying to jump on the covid bandwagon. What is the current MCAP now post dillution anyone know?
Brdgs

Does anyone know how much cash these guys have left from the £80million raised back in Oct last year? Also any idea why Polar are still reducing according to recent RNS?

Anyone know why the muted day today for this? as Kanabo seems to have done well, also fairly large trades posted on this also. Strange the price hasnt really done much but retract a bit.

I have been looking at this one and like the fundamentals, cant quite work out why the sustained fall over last few months, any wise words on this? I think ligation industry will be in use very soon if not already over various matters..

Maybe, but I have seen a lot of talk about this stock, I have been skeptical, having seen the corporate broker TPI who I do not think have a great track record in my opinon. Note today Lombard Odier TR1 have reduced their position, I am wondering why that is..

Thanks valuerebel, how could one have purchased these at the ipo price? I see that they came on with an approximate 33m MCAP and have more than doubled this already, I am one that prefers to buy value rather than chase the crowd..

Anyone feel that there is spread games here? I think I am interesting in this, but at ideally a far lower level, the number of shares in issue is a major put off.

didnt these guys raise a while back? What is the premise to buy into this? shocking recent performance, feel sorry for LTHs here..

how does everyone think the sheer number of shares in issue or warrants could affect the price? assuming this one comes up with any decent updates?!

spread here is a joke imho..